Home/Filings/4/0001181431-12-038588
4//SEC Filing

Grinstead Eric 4

Accession 0001181431-12-038588

CIK 0000911326other

Filed

Jun 28, 8:00 PM ET

Accepted

Jun 29, 8:11 PM ET

Size

5.3 KB

Accession

0001181431-12-038588

Insider Transaction Report

Form 4
Period: 2012-06-27
Grinstead Eric
SVP, Commercial Operations
Transactions
  • Award

    Stock Option (Right to Buy)

    2012-06-27+43,00043,000 total
    Exercise: $40.74Exp: 2022-06-27Common Stock (43,000 underlying)
Footnotes (1)
  • [F1]25% of the total number of shares subject to the option vest and become exercisable on June 27, 2013 and 1/36 of the remainder of the shares subject to the option shall vest and become exercisable monthly thereafter.

Issuer

SYNAGEVA BIOPHARMA CORP

CIK 0000911326

Entity typeother

Related Parties

1
  • filerCIK 0001532221

Filing Metadata

Form type
4
Filed
Jun 28, 8:00 PM ET
Accepted
Jun 29, 8:11 PM ET
Size
5.3 KB